These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [New evidence of conjugated estrogen and 17beta-estradiol for treatment and prevention of osteoporosis]. Kurabayashi T Nihon Rinsho; 2007 Nov; 65 Suppl 9():369-73. PubMed ID: 18161134 [No Abstract] [Full Text] [Related]
3. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy? Shulman LP J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108 [No Abstract] [Full Text] [Related]
4. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis]. Ribot C; Tremollieres F; Pouilles JM Ann Med Interne (Paris); 2000 Oct; 151(6):490-6. PubMed ID: 11104929 [TBL] [Abstract][Full Text] [Related]
5. Are the benefits of low-dose estrogens really proven? Studd J Climacteric; 2008 Oct; 11(5):438. PubMed ID: 18781491 [No Abstract] [Full Text] [Related]
6. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis. Levine JP Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027 [TBL] [Abstract][Full Text] [Related]
7. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety. Crandall C J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124 [TBL] [Abstract][Full Text] [Related]
8. [Estrogen replacement therapy in menopause]. Lanchares JL An Med Interna; 1991 Dec; 8 Suppl 3():35-42. PubMed ID: 1793790 [No Abstract] [Full Text] [Related]
9. Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial. Schaefers M; Muysers C; Alexandersen P; Christiansen C Menopause; 2009; 16(3):559-65. PubMed ID: 19423999 [TBL] [Abstract][Full Text] [Related]
10. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy. Richman S; Edusa V; Fadiel A; Naftolin F Menopause; 2006; 13(1):148-55. PubMed ID: 16607111 [TBL] [Abstract][Full Text] [Related]
11. Postmenopausal osteoporosis and hormone replacement therapy. Gambacciani M; Vacca F Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435 [TBL] [Abstract][Full Text] [Related]
12. [Use of estrogens during and after menopause]. Falch JA; Halse J Tidsskr Nor Laegeforen; 1991 May; 111(12):1529. PubMed ID: 2042196 [No Abstract] [Full Text] [Related]
17. [Evidence-based medicine and drug selection of osleoporosis prevention after menopause]. Xu L Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):265-6. PubMed ID: 15059503 [No Abstract] [Full Text] [Related]
18. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis]. Urano T Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770 [TBL] [Abstract][Full Text] [Related]
19. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis]. Higuchi T; Mizunuma H Clin Calcium; 2008 Aug; 18(8):1141-6. PubMed ID: 18677052 [TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy (ET) after menopause. Peck WA J Am Med Womens Assoc (1972); 1990; 45(3):87-90. PubMed ID: 2335696 [No Abstract] [Full Text] [Related] [Next] [New Search]